173 related articles for article (PubMed ID: 26406420)
1. Collagen degradation products measured in serum can separate ovarian and breast cancer patients from healthy controls: A preliminary study.
Bager CL; Willumsen N; Leeming DJ; Smith V; Karsdal MA; Dornan D; Bay-Jensen AC
Cancer Biomark; 2015; 15(6):783-8. PubMed ID: 26406420
[TBL] [Abstract][Full Text] [Related]
2. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.
Kehlet SN; Sanz-Pamplona R; Brix S; Leeming DJ; Karsdal MA; Moreno V
Sci Rep; 2016 Jul; 6():30599. PubMed ID: 27465284
[TBL] [Abstract][Full Text] [Related]
3. Remodeling of the Tumor Microenvironment Predicts Increased Risk of Cancer in Postmenopausal Women: The Prospective Epidemiologic Risk Factor (PERF I) Study.
Bager CL; Willumsen N; Kehlet SN; Hansen HB; Bay-Jensen AC; Leeming DJ; Dragsbæk K; Neergaard JS; Christiansen C; Høgdall E; Karsdal M
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1348-55. PubMed ID: 27411352
[TBL] [Abstract][Full Text] [Related]
4. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls.
Willumsen N; Bager CL; Leeming DJ; Smith V; Karsdal MA; Dornan D; Bay-Jensen AC
BMC Cancer; 2013 Nov; 13():554. PubMed ID: 24261855
[TBL] [Abstract][Full Text] [Related]
6. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts.
Lipton A; Leitzel K; Ali SM; Polimera HV; Nagabhairu V; Marks E; Richardson AE; Krecko L; Ali A; Koestler W; Esteva FJ; Leeming DJ; Karsdal MA; Willumsen N
Int J Cancer; 2018 Dec; 143(11):3027-3034. PubMed ID: 29923614
[TBL] [Abstract][Full Text] [Related]
7. Serum and urine markers of collagen degradation reflect renal fibrosis in experimental kidney diseases.
Papasotiriou M; Genovese F; Klinkhammer BM; Kunter U; Nielsen SH; Karsdal MA; Floege J; Boor P
Nephrol Dial Transplant; 2015 Jul; 30(7):1112-21. PubMed ID: 25784725
[TBL] [Abstract][Full Text] [Related]
8. The collagen turnover profile is altered in patients with inguinal and incisional hernia.
Henriksen NA; Mortensen JH; Sorensen LT; Bay-Jensen AC; Ågren MS; Jorgensen LN; Karsdal MA
Surgery; 2015 Feb; 157(2):312-21. PubMed ID: 25616945
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover.
Siebuhr AS; Petersen KK; Arendt-Nielsen L; Egsgaard LL; Eskehave T; Christiansen C; Simonsen O; Hoeck HC; Karsdal MA; Bay-Jensen AC
Osteoarthritis Cartilage; 2014 Jan; 22(1):44-50. PubMed ID: 24216059
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Matrix Fragments of the Basement Membrane and the Interstitial Matrix Are Serological Markers of Intestinal Tissue Remodeling and Disease Activity in Dextran Sulfate Sodium Colitis.
Lindholm M; Manon-Jensen T; Madsen GI; Krag A; Karsdal MA; Kjeldsen J; Mortensen JH
Dig Dis Sci; 2019 Nov; 64(11):3134-3142. PubMed ID: 31123972
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of circulating collagen turnover markers in very early systemic sclerosis.
Dobrota R; Jordan S; Juhl P; Del Papa N; Maurer B; Becker M; Mihai C; Bay-Jensen AC; Karsdal MA; Siebuhr AS; Distler O
RMD Open; 2024 May; 10(2):. PubMed ID: 38806188
[TBL] [Abstract][Full Text] [Related]
12. Combined antiretroviral therapy attenuates hepatic extracellular matrix remodeling in HIV patients assessed by novel protein fingerprint markers.
Leeming DJ; Anadol E; Schierwagen R; Karsdal MA; Byrjalsen I; Nielsen MJ; Schwarzer-Zander C; Boesecke C; Bendtsen F; Møller S; Strassburg CP; Spengler U; Krag A; Rockstroh J; Trebicka JK
AIDS; 2014 Sep; 28(14):2081-90. PubMed ID: 25136933
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive biomarkers derived from the extracellular matrix associate with response to immune checkpoint blockade (anti-CTLA-4) in metastatic melanoma patients.
Jensen C; Madsen DH; Hansen M; Schmidt H; Svane IM; Karsdal MA; Willumsen N
J Immunother Cancer; 2018 Dec; 6(1):152. PubMed ID: 30567561
[TBL] [Abstract][Full Text] [Related]
14. Neo-Epitopes--Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis.
Maijer KI; Gudmann NS; Karsdal MA; Gerlag DM; Tak PP; Bay-Jensen AC
PLoS One; 2016; 11(3):e0149329. PubMed ID: 27019199
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain.
Port H; Nielsen SH; Madsen SF; Bay-Jensen AC; Karsdal M; Seven S; Sørensen IJ; Morsel-Carlsen L; Østergaard M; Pedersen SJ
Arthritis Res Ther; 2022 Jun; 24(1):152. PubMed ID: 35739562
[TBL] [Abstract][Full Text] [Related]
16. Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.
Willumsen N; Bager CL; Leeming DJ; Smith V; Christiansen C; Karsdal MA; Dornan D; Bay-Jensen AC
Cancer Med; 2014 Oct; 3(5):1136-45. PubMed ID: 25044252
[TBL] [Abstract][Full Text] [Related]
17. Metabolites of type I, II, III, and IV collagen may serve as markers of disease activity in axial spondyloarthritis.
Hušáková M; Bay-Jensen AC; Forejtová Š; Zegzulková K; Tomčík M; Gregová M; Bubová K; Hořínková J; Gatterová J; Pavelka K; Siebuhr AS
Sci Rep; 2019 Aug; 9(1):11218. PubMed ID: 31375691
[TBL] [Abstract][Full Text] [Related]
18. Serological investigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.
Leeming DJ; Sand JM; Nielsen MJ; Genovese F; Martinez FJ; Hogaboam CM; Han MK; Klickstein LB; Karsdal MA
Biomark Insights; 2012; 7():119-26. PubMed ID: 23012495
[TBL] [Abstract][Full Text] [Related]
19. Urinary collagen degradation products as early markers of progressive renal fibrosis.
Hijmans RS; Rasmussen DG; Yazdani S; Navis G; van Goor H; Karsdal MA; Genovese F; van den Born J
J Transl Med; 2017 Mar; 15(1):63. PubMed ID: 28320405
[TBL] [Abstract][Full Text] [Related]
20. CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitis.
Siebuhr AS; Bay-Jensen AC; Karsdal MA; Lories RJ; de Vlam K
Biomark Med; 2016; 10(2):197-208. PubMed ID: 26764293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
